[Current spread of HPN and its forecast--especially in the dual therapy of HPN and HOT].
In 1999, Terumo's home healthcare network 'Home-Joint' managed more than 1,000 patients who underwent home parenteral nutrition (HPN). This spread of HPN led some patients to undergo another home medical treatment during the same period. This report evaluates the patients who underwent dual home therapy (HPN and HOT: home oxygen therapy) in comparison with patients who underwent HPN only. 1. Single HPN patients in 1999. Number: 1,034 (male 57%), age: 1-99 (mean 65, 43% over 70), diagnosis: cancer 52%, therapeutic periods: 1-437 days (mean 81). 2. Dual HPN-HOT patients in 1999. Number: 27 (male 70%), age: 44-94 (mean 75, 70% over 70), diagnosis: cancer 59%, therapeutic periods: HPN 1-388 days (mean 91), HOT 1-827 days (mean 99). 3. Adoption of dual HPN-HOT therapy. It is suggested that the dual HPN-HOT therapy may be adopted for at least the following two types of patients. 1) Pulmonary failure with HPN, 2) Malnutrition on HOT.
Watanabe
M
M
Terumo Corporation, Home Healthcare Business Unit.
Sawai
K
K
Ono
K
K
Natsuaki
T
T
Takashima
T
T
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D018575:Home Care Services, Hospital-Based; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D016331:Parenteral Nutrition, Home